To include your compound in the COVID-19 Resource Center, submit it here.

QS-21 flu vaccine: Began Phase I trial

Aquila Biopharmaceuticals Inc. (AQLA), Framingham, Mass.
Product: QS-21

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE